VAZALORE
Plx Pharma Inc.
Mark For: VAZALORE™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87679090 |
| Mark Literal Elements | VAZALORE |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-06-23 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Joseph C. Gioconda, Esq. |
| Attorney Docket Number | PLX04 |
| Law Office Assigned | M60 |
| Employee Name | SOUDERS, MICHAEL J |
Timeline
| 2017-11-09 | Application Filed |
| 2018-03-27 | Published |
| 2018-03-27 | Published for Opposition |
| 2019-07-11 | Location: INTENT TO USE SECTION |
| 2019-11-22 | Status: Live/Pending |
| 2019-11-26 | Transaction Date |
| 2020-06-23 | Location: INTENT TO USE SECTION |
| 2020-06-23 | Status: A fourth request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  PLX PHARMA INC. |
| Address | 9 Fishers Lane Sparta, NEW JERSEY UNITED STATES 07871 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-06-24 | |
| NOTICE OF REVIVAL - E-MAILED | 2020-06-23 | |
| EXTENSION 4 GRANTED | 2020-06-23 | 65362 |
| TEAS PETITION TO REVIVE RECEIVED | 2020-06-22 | |
| PETITION TO REVIVE-GRANTED | 2020-06-22 | 88889 |
| EXTENSION RECEIVED WITH TEAS PETITION | 2020-06-22 | |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2020-06-22 | |
| ABANDONMENT - NO USE STATEMENT FILED | 2020-06-22 | 99999 |
| EXTENSION 4 FILED | 2020-05-22 | 65362 |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-02-12 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-02-12 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-11-26 | |
| TEAS EXTENSION RECEIVED | 2019-11-22 | |
| EXTENSION 3 GRANTED | 2019-11-22 | 98765 |
| EXTENSION 3 FILED | 2019-11-22 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-07-12 | |
| EXTENSION 2 GRANTED | 2019-07-11 | 65362 |
| TEAS PETITION TO REVIVE RECEIVED | 2019-07-08 | |
| PETITION TO REVIVE-GRANTED | 2019-07-08 | 88889 |
| NOTICE OF REVIVAL - E-MAILED | 2019-07-08 | |
| EXTENSION RECEIVED WITH TEAS PETITION | 2019-07-08 | |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-06-24 | |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-06-24 | 99999 |
| EXTENSION 2 FILED | 2019-05-22 | 65362 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-02-08 | |
| EXTENSION 1 GRANTED | 2019-02-07 | 65362 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-02-07 | 65362 |
| TEAS PETITION TO REVIVE RECEIVED | 2018-12-04 | |
| PETITION TO REVIVE-GRANTED | 2018-12-04 | 88889 |
| NOTICE OF REVIVAL - E-MAILED | 2018-12-04 | |
| EXTENSION RECEIVED WITH TEAS PETITION | 2018-12-04 | |
| EXTENSION 1 FILED | 2018-11-22 | 65362 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-05-22 | |
| PUBLISHED FOR OPPOSITION | 2018-03-27 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-03-27 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-03-07 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-02-22 | |
| ASSIGNED TO EXAMINER | 2018-02-21 | 76596 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-11-20 | |
| NEW APPLICATION ENTERED IN TRAM | 2017-11-13 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VAZALORE 90157665 not registered Live/Pending |
PLX PHARMA INC. 2020-09-03 |
 VAZALORE 88756309 not registered Live/Pending |
PLx Pharma Inc. 2020-01-13 |
 VAZALORE 88677340 not registered Live/Pending |
PLx Pharma, Inc. 2019-11-01 |
 VAZALORE 87679090 not registered Live/Pending |
PLX PHARMA INC. 2017-11-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 